Patent · US Revoked

Oligosaccharide compound for inhibiting intrinsic coagulation factor X-enzyme complex, and preparation method therefor and uses thereof

US11833169B2 · kind B2 · utility

0Cited by
1References
10Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 10, 2017
Grant dateDec 5, 2023
Priority date
Expiry dateOct 8, 2039

Classification

  • Technology area (CPC —)General

Abstract

A purified oligosaccharide compound having antithrombotic activity or a mixture of a homologous compound thereof and a pharmaceutically acceptable salt thereof, a preparation method for the mixture, a pharmaceutical composition containing the mixture, and uses thereof serving as an intrinsic factor X-enzyme (Xase) inhibitor in the preparation of drugs for preventing and/or treating thrombotic diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.